Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines
Clinical trial NCT05150834 · UNKNOWN
Trial details
- NCT number
- NCT05150834
- Sponsor
- Korea University Guro Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-07-16
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.